immunepharmaceuticals.investorroom.com

InvestorRoom D - News Releases

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Aug 11, 2015. Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call. Jul 29, 2015. Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors. Jul 17, 2015. Jul 13, 2015. Immune Pharm...

http://immunepharmaceuticals.investorroom.com/

OVERVIEW OF immunepharmaceuticals.investorroom.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNEPHARMACEUTICALS.INVESTORROOM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 13 reviews

5 star

6

4 star

4

3 star

3

2 star

0

1 star

0

Hey there! Start your review of immunepharmaceuticals.investorroom.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.7 seconds

CONTACTS AT IMMUNEPHARMACEUTICALS.INVESTORROOM.COM

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

5

SSL

EXTERNAL LINKS

0

SITE IP

64.78.159.10

LOAD TIME

0.686 sec

SCORE

6.2

PAGE TITLE

InvestorRoom D - News Releases | immunepharmaceuticals.investorroom.com Reviews

<META> DESCRIPTION

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Aug 11, 2015. Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call. Jul 29, 2015. Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors. Jul 17, 2015. Jul 13, 2015. Immune Pharm...

<META> KEYWORDS

1 archives search

2 news releases

3 sec filings

4 financial reporting

5 investor alerts

6 coupons

7 reviews

8 scam

9 fraud

10 hoax

CONTENT

Page content here

KEYWORDS ON PAGE

archives search,news releases,sec filings,financial reporting,investor alerts

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

InvestorRoom D - News Releases | immunepharmaceuticals.investorroom.com Reviews

https://immunepharmaceuticals.investorroom.com

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Aug 11, 2015. Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call. Jul 29, 2015. Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors. Jul 17, 2015. Jul 13, 2015. Immune Pharm...

INTERNAL PAGES

immunepharmaceuticals.investorroom.com

1

Immune Pharmaceuticals (Immune) Amends Pain Licensing Agreement - Jul 8, 2015

http://immunepharmaceuticals.investorroom.com/2015-07-08-Immune-Pharmaceuticals-Immune-Amends-Pain-Licensing-Agreement

Immune Pharmaceuticals (Immune) Amends Pain Licensing Agreement. Jul 8, 2015. July 8, 2015. Immune will re-gain full exclusive rights to develop, commercialize and license LidoPain , a high-dose lidocaine patch for the treatment of acute pain. LidoPain is currently in Phase II clinical development. About Immune Pharmaceuticals Inc. For more information, visit Immune's website at www.immunepharmaceuticals.com. Or at www.immunepharmaceuticals.com. SOURCE Immune Pharmaceuticals Inc.

2

Immune Pharmaceuticals to present bertilimumab at The International Eosinophil Society workshop on Personalized Medicine - Jul 13, 2015

http://immunepharmaceuticals.investorroom.com/2015-07-13-Immune-Pharmaceuticals-to-present-bertilimumab-at-The-International-Eosinophil-Society-workshop-on-Personalized-Medicine

Immune Pharmaceuticals to present bertilimumab at The International Eosinophil Society workshop on Personalized Medicine. Jul 13, 2015. July 13, 2015. Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced today that it will participate in the Personalized Medicine: Novel Targeted Biologics for Rare Eosinophilic Diseases workshop on July 14, 2015. Preceding the July 15-18, 2015. Biennial International Eosinophil Society Symposium in Chicago, IL. Recently, Immune initiated patient enrollment for phase II cl...

3

Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call - Aug 11, 2015

http://immunepharmaceuticals.investorroom.com/2015-08-11-Immune-Pharmaceuticals-Announces-Corporate-Update-and-Second-Quarter-2015-Financial-Results-Conference-Call

Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call. Aug 11, 2015. Aug 11, 2015. Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: IMNP) announced today that it plans to release its second quarter 2015 financial results on Friday ,. August 14, 2015. After U.S. market close. In connection with the earnings release, Immune will host its first quarterly conference call and live audio webcast at 8:00 am EDT on Monday. August 17, 2015. At 11:30 am EDT.

4

Immune Pharmaceuticals Joins The Russell Microcap Index - Jul 17, 2015

http://immunepharmaceuticals.investorroom.com/2015-07-17-Immune-Pharmaceuticals-Joins-The-Russell-Microcap-Index

Immune Pharmaceuticals Joins The Russell Microcap Index. Jul 17, 2015. July 17, 2015. Immune Pharmaceuticals Inc. (NASDAQ: IMNP) today announced that it has joined the Russell Microcap Index at the conclusion of the Russell indexes annual reconstitution on June 26, 2015. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Immune Pharmaceuticals Executive Vice President and Chief Financial Officer, Gad Berdugo. FTSE Russel...

5

Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors - Jul 29, 2015

http://immunepharmaceuticals.investorroom.com/2015-07-29-Immune-Pharmaceuticals-secures-funding-of-up-to-21-5-Million-from-institutional-Investors

Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors. Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing. Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates. Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority. Jul 29, 2015. July 29, 2015. Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced today that it has secured financings of up to $21.5 million. In gross proceeds to the company.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

OTHER SITES

immunepath.circuitblue.com

ImmunePath, Inc.

Menlo Park, CA 94025.

immunepath.com

HostDime Web Hosting

Menlo Park, CA 94025.

immunepc.com

Immune PC Corporation

Future Home of Immune PC Corporation.

immunepharma.com

Immune Pharmaceuticals

Information to the Swedish Markets. Press Releases – Sweden. News & Events. Is a member of the Crohn's and Colitis Foundation of America (CCFA) President's Corporate Circle. PRESS RELEASE March 12, 2018. Immune Pharmaceuticals Announces Acceptance of Abstract at 2018 Pre-IID Pemphigus and Pemphigoid Symposium Read more. PRESS RELEASE February 27, 2018. Immune Pharmaceuticals Announces Outcome of Annual Meeting of Stockholders Read more. PRESS RELEASE February 20, 2018. No upcoming events found.

immunepharmaceuticals.com

Immune Pharmaceuticals Inc. אימיון פארמסוטיקלסImmune Pharmaceuticals

Information to the Swedish Markets. Click Here To Play Video. Immune Pharmaceuticals to Advance its Immuno-Dermatology and Inflammatory. Bowel Disease Product Candidates. IMMUNE is focused on developing the next generation of monoclonal antibodies to. Address significant unmet medical needs in. The treatment of cancer and inflammatory diseases. Our goal is to improve patients’ lives through targeted medicine. Immune Pharmaceuticals presented at the Virtual InvestorConferences.com.

immunepharmaceuticals.investorroom.com

InvestorRoom D - News Releases

These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Aug 11, 2015. Immune Pharmaceuticals Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call. Jul 29, 2015. Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors. Jul 17, 2015. Jul 13, 2015. Immune Pharm...

immunepowder.com

Welcome to Amazon Planet, home of Wonderfruit Açai

ARE YOU A FOODSERVICE OPERATOR? Whatever açai you use, we've got you covered! Now distributing our super-premium acai products in Los Angeles and Orange County with the one and only AçaiMobile . Made in the Amazon. Within hours of the berries being picked. Discover our new Sorbets. Learn how to craft your own delicious açai bowl. Because it combines the best of both worlds.

immunepowder.net

Welcome to Amazon Planet, home of Wonderfruit Açai

ARE YOU A FOODSERVICE OPERATOR? Whatever açai you use, we've got you covered! Now distributing our super-premium acai products in Los Angeles and Orange County with the one and only AçaiMobile . Made in the Amazon. Within hours of the berries being picked. Discover our new Sorbets. Learn how to craft your own delicious açai bowl. Because it combines the best of both worlds.

immunepower.org

Increase Immune Power with Immunocal and Immunocal Platinum

immunepowerhealth.blogspot.com

Immune Power Health Blog

Immune Power Health Blog. Sunday, April 25, 2010. The Joy of Sharing. My name is Laura Wilder – Yes it is my real name! 8211; Laura Williams Wilder. Later in my blog I will tell you the amazing story of how I got my name, but I will share some equally amazing stories before. Please feel free to share this site with others that you think might be blessed by reading the E Book and the blog. God bless and keep you. If it were my regular chiropractor, he would have known that there was something wrong immedi...

immunepowerhealth.max.com

Max International

HealthyQualityOfLife.com-HealthyQOL.com-NewQOL.com. Email Questions or Comments to NewQOL@gmail.com. Loading the player . Max4U™ User Agreement.